Relevance. Approximately 90–100% of patients have skin toxicity, which manifests itself in the form of acne-like rashes (papulo-pustular rash), paronychia, hair changes, xerosis, itching. Skin manifestations cause psychological, emotional and physical discomfort, which may be the reason for dose reduction or discontinuation of treatment, and may reduce the effectiveness of antitumor therapy. The use of modern telemedicine systems, such as online consultations and remote monitoring, are designed to make life easier for patients and are now increasingly available and in demand among the general population. The aim of the study. Assessment of the quality of life in cancer patients receiving EGFR inhibitors, depending on the use of remote consultations and remote monitoring.Materials and methods. 140 cancer patients were included in the study. All patients were divided into two groups: in group 1 (study group) n=70, the mobile application «My Health» was used for online-consultation with a dermatologist, in group 2 (comparison group) n=70, offline consultations were used. During the consultations, skin toxicity was assessed using CTCAE scales version 5.0. To analyze the level of quality of life, a questionnaire of the dermatological quality of life index (DLQI) was used, which patients of each group filled out on the day of the start of the study, then after 4 weeks.Results. In patients of the first group, there was a positive dynamic in the state of the skin process compared with the initial indicators. There was a statistically significant improvement in the quality of life, a decrease in the average score for all indicators. In patients of the second group, the positive dynamics of the skin process was not so obvious, as evidenced by the results of the questionnaire. There was a statistically significant strong direct correlation between the value of the results of DLQI and the severity of the disease (rs=0.721 p <0.001).Conclusion. Skin toxicity is a complex interdisciplinary problem that requires an integrated approach between oncologists and dermatologists. Remote monitoring is an accessible form of communication between a doctor and a patient, which contributes to the timely control of skin toxicity in cancer patients receiving EGFR inhibitors.
Read full abstract